Live Breaking News & Updates on Richarde Lowenthal

Stay updated with breaking news from Richarde lowenthal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) CEO Richard E. Lowenthal Sells 5,147 Shares of Stock

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) CEO Richard E. Lowenthal Sells 5,147 Shares of Stock
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

William Blair , Leerink Partnrs , Richarde Lowenthal , Pharmaceuticals Price Performance , Pharmaceuticals Daily , Paloma Partners Management Co , China Universal Asset Management Co , Russell Investments Group Ltd , Ars Pharmaceuticals Inc , Nisa Investment Advisors , Pharmaceuticals Inc , Get Free Report , Investment Advisors , Investments Group , Universal Asset Management ,

Richard E. Lowenthal Sells 95,267 Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Stock

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) CEO Richard E. Lowenthal sold 95,267 shares of ARS Pharmaceuticals stock in a transaction on Monday, March 25th. The shares were sold at an average price of $9.12, for a total transaction of $868,835.04. Following the sale, the chief executive officer now directly owns 1,697,447 shares of […] ....

United States , Leerink Partnrs , Richarde Lowenthal , William Blair , Ars Pharmaceuticals Inc , Group Plc , American Century Companies Inc , Pharmaceuticals Inc , Charles Schwab Investment Management Inc , Pharmaceuticals Stock Performance , Nisa Investment Advisors , Pharmaceuticals Daily , Get Free Report , General Group Plc , Schwab Investment Management , Century Companies , Investment Advisors ,

ARS Pharmaceuticals (NASDAQ:SPRY) Reaches New 1-Year High at $9.75

ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) shares reached a new 52-week high during trading on Tuesday . The stock traded as high as $9.75 and last traded at $9.73, with a volume of 978686 shares trading hands. The stock had previously closed at $9.13. Analyst Ratings Changes Several analysts have issued reports on […] ....

Richarde Lowenthal , William Blair , Leerink Partnrs , Pharmaceuticals Daily , Ars Pharmaceuticals Inc , Pharmaceuticals Stock , Barclays Plc , Cubist Systematic Strategies , Capital Partners , Pharmaceuticals Inc , Nantahala Capital Management , Get Free Report , Capital Management , Ars Pharmaceuticals , Nasdaq Spry ,